News
News from us and our partners
News
News
Biovelocita
News
Crossover
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
CEO spotlight: Thierry Abribat's third straight win
Sofinnova’s newest partners discuss their career paths
Sofinnova publishes 2023 Impact Report
Johnson & Johnson to acquire Shockwave Medical
Cure51 raises €15 million to harness the power of cancer survivors
CEO spotlight: CinCor's Marc de Garidel
Tags
Topics
0 results
- News
World First: CorWave's Undulating Membrane Heart Pump Implanted in First Patient
- News
Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy
- News
ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
- News
TISSIUM Receives FDA De Novo Authorization for COAPTIUM® CONNECT in atraumatic sutureless peripheral nerve repair
- News
Moon Surgical Expands Leadership Team to Accelerate Commercial Growth Across U.S. and Europe
- News
Micropep and Corteva announce multi-year research collaboration to advance sustainable biocontrol solutions
- News
Gradient Denervation Technologies announces acceptance into FDA’s Total Product Life Cycle Advisory Program for development of its pulmonary artery denervation system
- News
AFYREN begins new phase of industrial strategy as first plant AFYREN NEOXY achieves continuous production
- News
eXmoor Pharma and Signadori Bio launch partnership to develop next-generation monocyte-based cell therapy for solid tumours
- News
Sofinnova Partners collaborates with NVIDIA to accelerate European life sciences startups
- News
Mediar Therapeutics Doses First Patient in Phase 2 WISPer Trial of MTX-463 for Idiopathic Pulmonary Fibrosis
- News
Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for BRIMOCHOL™ PF for the Treatment of Presbyopia
- News
Enthera Pharmaceuticals Announces Publication in the Journal of Clinical Investigation Supporting the Clinical Development of Ebrasodebart
- News
GlycoEra AG raises $130 million to advance novel pipeline of extracellular protein degraders for the treatment of autoimmune diseases
- News
Biotalys and AgroFresh Partner to protect fresh produce